Artificial Intelligence (AI) In Medical Writing Market Growth Outlook Through 2024-2033

 

Artificial intelligence (AI) in medical writing refers to the application of intelligence technologies to streamline and enhance the process of creating medical documents, such as research papers, clinical trial reports, regulatory submissions, patient information leaflets, and other healthcare-related content. AI enhances efficiency, accuracy, and accessibility in medical writing tasks, contributing to advancements in medical research and healthcare delivery.

Sizing and Forecast
The artificial intelligence (AI) in medical writing market size has grown rapidly in recent years. It will grow from $0.79 billion in 2023 to $0.91 billion in 2024 at a compound annual growth rate (CAGR) of 15.2%.  The  growth in the historic period can be attributed to the rise in contract research organization outsourcing, rising cost of medical writing, trade agreements and government policies, the increased complexity in the approval of regulatory process and growing need for accurate and reliable medical content.

The artificial intelligence (AI) in medical writing market size is expected to see rapid growth in the next few years. It will grow to $1.62 billion in 2028 at a compound annual growth rate (CAGR) of 15.3%.  The growth in the forecast period can be attributed to the promising environment for clinical study, increasing adoption of telemedicine and remote healthcare services, expanding digital infrastructure, growing awareness of AI's potential benefits in healthcare, and the growing need for accurate and reliable medical content. Major trends in the forecast period include advancements in natural language processing (NLP) and machine learning algorithms, adoption of machine learning (ML), the rise of digital health services, integration with emerging technologies, and advancements in clinical decision support systems.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-medical-writing-global-market-report

Segmentation & Regional Insights
The artificial intelligence (AI) in medical writing market covered in this report is segmented –
1) By Type: Clinical Writing, Type Writing, Scientific Writing, Other Types
2) By Application:  Regulatory Documentation, Automated Literature Review, Language Translation, Pharmacovigilance, Content Modularization
3) By End Use: Medical Devices, Pharmaceutical, Biotechnology, Other End Users

North America was the largest region in the artificial intelligence (AI) in medical writing market in 2023. The regions covered in the artificial intelligence (AI) in medical writing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16590&type=smp

Major Driver Impacting Market Growth
Increasing demand for new pharmaceutical drugs and therapies is expected to propel the growth of artificial intelligence (AI) in the medical writing market going forward. The increasing demand for new pharmaceutical drugs and therapies is driven by the continual need to address unmet medical needs, treat emerging diseases, combat drug resistance, and improve patient outcomes through innovative and more effective treatments. AI in medical writing within the pharmaceutical and drug production sectors enhances efficiency, accuracy, and innovation, contributing to the development of safer and more effective therapies for various medical conditions. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $384,200 million (€340,000 million) in 2022, an increase of approximately 4.95% from 366,267 million (€323,950 million) in 2021. Therefore, increasing demand for new pharmaceutical drugs and therapies will drive the growth of artificial intelligence (AI) in the medical writing market.

Key Industry Players
Major companies operating in the artificial intelligence (AI) in medical writing market are  International Business Machines Corporation, IQVIA Holdings Inc., Icon PLC, Syneos Health Pvt Ltd, Parexel International Corporation, Veeva Systems, Cactus Communications, Tata Elxsi, Allucent Inc , Certara Inc , Freyr Solutions , Amplity Health, Indegen Limited, MMS Holdings Inc., Jasper AI Inc, Symbiance AI Inc, GenInvo Technologies Pvt. Ltd., Trilogy Writing & Consulting GmbH, Yseop S.A.S., Turacoz Healthcare Solution, Averbis GmbH, EMTEX Life Sciences, DeepCura AI, Dezzai Inc , Narrativa Inc

The artificial intelligence (ai) in medical writing market report table of contents includes:
1. Executive Summary

2. Artificial Intelligence (AI) In Medical Writing Market Characteristics

3. Artificial Intelligence (AI) In Medical Writing Market Trends And Strategies

4. Artificial Intelligence (AI) In Medical Writing Market - Macro Economic Scenario

5. Global Artificial Intelligence (AI) In Medical Writing Market Size and Growth


.
32. Global Artificial Intelligence (AI) In Medical Writing Market Competitive Benchmarking

33. Global Artificial Intelligence (AI) In Medical Writing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Medical Writing Market

35. Artificial Intelligence (AI) In Medical Writing Market Future Outlook and Potential Analysis

36. Appendix

Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more